Skip to content
drillr.ai
Sign up

00455.HK

Tianda Pharmaceuticals Limited

HKSE · Healthcare · Drug Manufacturers - Specialty & Generic · HK

HKD 0.10
+0.99%
Ask drillr

  • Aug 10, 2026, 16:10 UTC

    Tianda Pharmaceutical announced its interim results for the six months ended June 2026, with revenue of HK$164 million, up 20.2% year-on-year, net loss narrowed to HK$32.25 million, loss per share of HK$0.015, and no dividend.

    Source: